Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study

0 avis

Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study

Archive ouverte

Edité par CCSD ; Elsevier -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Association Between Initial Treatment Strategy and Long-term Survival in Pulmonary Arterial Hypertension

Archive ouverte | Boucly, Athénaïs | CCSD

International audience. Rationale: The relationship between the initial treatment strategy and survival in pulmonary arterial hypertension (PAH) remains uncertain. Objectives: To evaluate the long-term survival of p...

Corrigendum to: “Portopulmonary hypertension in the current era of pulmonary hypertension management” [J Hepatol (2020);73:130–139]

Archive ouverte | Savale, Laurent | CCSD

International audience

Portopulmonary hypertension in the current era of pulmonary hypertension management

Archive ouverte | Savale, Laurent | CCSD

International audience

Chargement des enrichissements...